Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

rTMS for Tobacco Use in Veterans

NCT: NCT07050862 · NOT_YET_RECRUITING

NCT IDNCT07050862
StatusNOT_YET_RECRUITING
Start Date2026-07-01
Completion2030-08-31

Brief Summary

Cigarette smoking is a significant public health concern for Veterans. Encouraging smoking cessation continues to be a top priority for the Veterans' Administration as Veterans who use tobacco experience negative health effects, including cancer, heart disease, and mental disorders. Despite the efficacy of current evidence-based pharmacotherapies and psychotherapies for smoking cessation, alternative treatments are critically needed. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive form of brain stimulation, US FDA-approved for smoking cessation. In this protocol, the investigators propose comparing the two rTMS protocols (standard TMS vs. precision TMS) to find a better treatment parameter for smoking cessation in Veterans. Identifying an efficacious rTMS protocol would benefit Veterans who want to quit smoking.

Frequently Asked Questions

What is rTMS for Tobacco Use in Veterans?

rTMS for Tobacco Use in Veterans is a clinical trial registered under NCT07050862. Current status: NOT_YET_RECRUITING.

What is the status of NCT07050862?

The current status of NCT07050862 (rTMS for Tobacco Use in Veterans) is: NOT_YET_RECRUITING.

When did rTMS for Tobacco Use in Veterans start?

rTMS for Tobacco Use in Veterans started on 2026-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.